Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Ziebermayr

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Breast Care (Basel, Switzerland)|July 23, 2011
Breast Cancer: Rank Ligand InhibitionRupert Bartsch, Guenther G Steger, Michael Gnant, et al.
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
Triple-negative breast cancerRupert Bartsch, Reinhard Ziebermayr, Christoph C Zielinski, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2014
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trialHans-Joachim Schmoll, Burghardt Wittig, Dirk Arnold, et al.
Nature Medicine|October 7, 2008
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisRenate Kain, Markus Exner, Ricarda Brandes, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Breast Care (Basel, Switzerland)|July 23, 2011
Breast Cancer: Rank Ligand InhibitionRupert Bartsch, Guenther G Steger, Michael Gnant, et al.
Wiener Medizinische Wochenschrift (1946)|May 18, 2010
Triple-negative breast cancerRupert Bartsch, Reinhard Ziebermayr, Christoph C Zielinski, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2014
Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trialHans-Joachim Schmoll, Burghardt Wittig, Dirk Arnold, et al.
Nature Medicine|October 7, 2008
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisRenate Kain, Markus Exner, Ricarda Brandes, et al.
Pageof 1